How Do You Like Them Apples? Apple (NASDAQ:AAPL) Closes up over 6% on News of Highest Quarterly Revenue and Earnings Ever

New York, New York - January 26, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, issues a trading and news alert for Apple (NASDAQ:AAPL) for January 25 th. The Company reported record revenue and earnings and the stock closed at $446.66, up 26.25(6.24%) on over 34 Million shares, with a high of $ 454.45.
Apple reported financial results for its fiscal 2012 first quarter which spanned 14 weeks and ended December 31, 2011. The Company posted record quarterly revenue of $46.33 billion and record quarterly net profit of $13.06 billion, or $13.87 per diluted share. These results compare to revenue of $26.74 billion and net quarterly profit of $6 billion, or $6.43 per diluted share, in the year-ago quarter. Gross margin was 44.7 percent compared to 38.5 percent in the year-ago quarter. International sales accounted for 58 percent of the quarter's revenue.
The Company sold 37.04 million iPhones in the quarter, representing 128 percent unit growth over the year-ago quarter. Apple sold 15.43 million iPads during the quarter, a 111 percent unit increase over the year-ago quarter. The Company sold 5.2 million Macs during the quarter, a 26 percent unit increase over the year-ago quarter. Apple sold 15.4 million iPods, a 21 percent unit decline from the year-ago quarter.
Apple news: http://www.investorideas.com/news/2012/main/01253.asp
Apple designs Macs, the best personal computers in the world, along with OS X, iLife, iWork and professional software. Apple leads the digital music revolution with its iPods and iTunes online store. Apple has reinvented the mobile phone with its revolutionary iPhone and App Store, and is defining the future of mobile media and computing devices with iPad.

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus https://plus.google.com/116622008917768549777
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more. Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411 - Source - www.Investorideas.com

Friday's NASDAQ Most Advanced; ZAGG, IDIX, BVSN, MNEL

POINT ROBERTS WA, January 16, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on the top five percentage gainers on the NASDAQ for Friday January 13th. The NASDAQ closed at 2710.67, down 14.03 or 0.51%. Markets are closed Monday, January 16th.

ZAGG Inc (NASDAQ:ZAGG) closed up at $ 8.10, up 0.97 13.60% on volume of 3,438,059 and continued its gains in after hours trading. On Wednesday last week the Company reported it introduced a new premium version of their patented film in the award-winning invisibleSHIELD® line at International CES 2012, called the invisibleSHIELD HD™. The new line offers industry-leading clarity and finish in a protective film, and is available online at ZAGG.com beginning January 12, as well as at ZAGG retail outlets, and through a select retail partner.
Idenix Pharmaceuticals, Inc (NASDAQ:IDIX) ended at $ 14.42, up 1.71 13.45%on 6,478,749 shares. The stock was up another 1.6% after hours. On January 9 th, the Company reported the advancement of its hepatitis C virus (HCV) development pipeline.
BroadVision, Inc. (NASDAQ:BVSN) finished the day at $ 17.59, up 2.04 13.12% on 300,415 shares, with a slight downtrend after hours. The Company announced that it will release its fourth quarter 2011 financial results on Thursday, January 26 at approximately 1:30PM Pacific Standard Time (PST).
Renewable energy stock, Mission NewEnergy Limited (NASDAQ:MNEL) closed up at $ 2.54, up 0.29 12.89%on 16,987 shares.
Array BioPharma Inc. (NASDAQ:ARRY) ended trading at $ 2.38, up 0.25 11.74% on volume of 832,017.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus https://plus.google.com/116622008917768549777
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more . Join:   http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411 - Source - www.Investorideas.com

Wednesday's NASDAQ Most Advanced; EMITF, ACRX, IESC, CCIH

POINT ROBERTS, WA - January 12, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on the four top percentage gainers on the NASDAQ for Wednesday January 11th. The NASDAQ closed up slightly at 2710.76, up 8.26 or 0.31%.

The top percentage gainer, Elbit Imaging Ltd. (NasdaqGS: EMITF), closed at $3.32 , moving up 0.7160 (27.50%). The thinly traded stock traded over 84,000 shares, up from its average volume of just 7819 . The Company reported sale of 47 real estatepProperties for US$1.428 Billion by EPN Group.
AcelRx Pharmaceuticals, Inc. (NasdaqGM: ACRX) had respectable gains of 26.48%, closing up at $2.77, up 0.58. ACRX is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain.
Integrated Electrical Services, (NasdaqGM: IESC) closed up at $2.40, up 0.49 (25.65%) on very light trading. Last Friday the Company announced the promotion of Robert Lewey to Senior Vice President and Chief Financial Officer to replace Terry Freeman upon his retirement from the Company, effective January 20 , 2012.
ChinaCache International Holdings (NasdaqGM: CCIH) ended at $6.85, up 1.17 (20.60%) on over 266,000 shares, two and a half times its normal trading volume. The Company announced in late December that it reached an agreement with the Shanxi branch of China Unicom and Shanxi Wentian Technology Co., Ltd , the first online game company in Shanxi province of China, to build Shanxi's largest cloud computing data center to enable facilities including disaster recovery centers, enterprise data centers and Internet data centers.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus https://plus.google.com/116622008917768549777
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more . Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411 - Source - www.Investorideas.com

Biopharmaceutical Stock to Watch: Idenix Pharmaceuticals (NASDAQ: IDIX) Soars on HCV Development News

Point Roberts, WA - January 9, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) following news of its HCV development pipeline. The stock is trading up at $9.36, up 2.31 (32.77%) 11:12AM EST with a high of $10.39.
Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) today announced the advancement of its hepatitis C virus (HCV) development pipeline.
IDX719: NS5A Program

Idenix announced today the initiation of a phase I clinical trial of the Company's NS5A inhibitor, IDX719. The first part of the study will evaluate safety, pharmacokinetics and food effect of IDX719 in 48 healthy volunteers. A subsequent part of the study will evaluate three days of IDX719 treatment in treatment-naïve genotype 1 HCV-infected patients and is expected to begin in the second quarter of 2012. Preclinical studies have shown that IDX719 has potent, pan-genotypic activity in vitro with the potential for once-daily dosing.
IDX19368 and IDX19370: Nucleotide Prodrug Program
Further, the Company has selected two additional nucleotide inhibitors, IDX19368 and IDX19370, as potential clinical candidates. The Company anticipates Investigational New Drug (IND) filings in mid-2012.
"Over the past year, Idenix has made significant progress in both our core nucleotide and NS5A programs," commented Ron Renaud, President and Chief Executive Officer of Idenix. "The preclinical profile of IDX719 is very competitive, and we are leveraging the Company's significant nucleotide chemistry expertise to discover novel nucleotides with promising properties as well as continuing to strengthen our IP position. We are excited about the potential of our novel antiviral compounds in the evolving HCV field in the coming year."
ABOUT IDENIX (NASDAQ: IDIX)
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with hepatitis C infection. For further information about Idenix, please refer to www.idenix.com.
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Thursday’s NASDAQ Winners: DNDN, ACOM, ZUMZ, OCLR

Dendreon (NASDAQ:DNDN) Soars On News of Revenue Growth

POINT ROBERTS, January 06, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Thursday January 05th. The Nasdaq ended higher by 21.50 (0.81%) closing at 2,669.86.

Dendreon Corporation (NASDAQ:DNDN) moved higher by 3.02 (39.74%) to close at $10.62 after the biotechnology company reported solid revenue growth in its fourth quarter. The company said that it revenue grew 230% year-over-year to about approximately $82 million.
Ancestry.com Inc (NASDAQ:ACOM) climbed 4.60 (20.11%) to end at $27.47 on very unusual volume of 3.37 million – over 4.50X its average volume. The company said that it total paying subscribers stood at 1,703,000 at the end of fourth quarter, beating its own target of 1,685,000 – 1,695,000 subscribers. The company also said that now it projects to see revenue growth in the mid-to-high teens for the FY2012.
Zumiez Inc.(NASDAQ:ZUMZ) was the biggest gainer in the retail sector and added 4.62 (17.55%) to end at $30.95 after the company said that it comparable sales grew 10%for the five-week period ending Dec. 31, ahead of analysts’ estimates of 5.1%. Moreover, the company lifted its earnings outlook to 57-58 cents on revenue of $180-$181 million for its fourth quarter, topping analysts’ estimates of 54 cents on revenue of $176.8 million.

Oclaro, Inc. (NASDAQ:OCLR) jumped 15.65% to close at $3.40 after the company reported better-than-estimated fiscal second quarter preliminary sales. The company generated sales of $86 million, beating analysts’ target of $80.8 million.

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp

Join Investor Ideas Get 13 of the best stock directories online;
Research biotech, oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp

800-665-0411 - Source – www.Investorideas.com

Wednesday's NASDAQ Percentage Winners: LCAV, GNOM, NLST, UNIS

POINT ROBERTS - January 5, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Wednesday January 04th. The Nasdaq closed flat at 2,648.36.

LCA-Vision Inc.(NASDAQ:LCAV) was the biggest percentage gainer and surged $1.09 or 35.39% to close at $4.17 after the company said that its volume for laser-vision correction services grew 40% quarter-over-quarter during its fourth quarter. The company’s total volume stood at 14,205 procedures during the period. The company also has scheduled its fourth-quarter results on Feb. 14.
Complete Genomics, Inc.(NASDAQ:GNOM) shares added 61 cents or 21.03% to close at $3.51 without any official news. The stock bounced back from its recent lows. Last week, the stock made a new 52-week low of $2.57 and has recovered over 36.50% since then , trading above its key technical moving averages.
Netlist, Inc.(NASDAQ:NLST) ended higher by 32 cents or 13.01% to close at $2.78, with more than 979K shares traded hands, its highest intraday volume in the past month. The stock is trading very near to its 50-Day Moving Average of $2.80, while above its 200-Day Moving Average of $1.92.
Unilife Corp(NASDAQ:UNIS) moved up 41 cents or 12.65% to close at $3.65, supported by positive ratings from analyst at Jefferies. The brokerage firm rerated the stock to buy and set a price target of $7, still representing a potential gain of 92%.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411 - Source - www.Investorideas.com